亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Abstract B026: Overcoming KRAS G12C inhibitor resistance with chaperone-mediated protein degrader in NSCLC

作者
Inés Pulido,Jennifer Graeber,Brianna C. Borger,Kevin P. Foley,Weiwen Ying,Chenghao Ying,Jinhua Li,Yaya Wang,Yuetong Sun,Yan Dai,Guoqiang Wang,Thomas L. Prince,Takeshi Shimamura
出处
期刊:Molecular Cancer Research [American Association for Cancer Research]
卷期号:21 (5_Supplement): B026-B026
标识
DOI:10.1158/1557-3125.ras23-b026
摘要

Abstract KRAS-G12C targeting inhibitors (G12Cis), such adagrasib and sotorasib, have shown specificity and promising anti-tumor potential in non-small cell lung carcinoma (NSCLC). However, acquired resistance to these inhibitors has recently been observed in the clinic. Mechanisms of resistance to G12Cis are associated with genetic alterations of several pro-growth signaling pathways. A strategy to overcome the multifarious resistance mechanisms to G12Cis that does not require further molecular characterization is needed. To develop an all-round strategy to overcome G12Ci resistance mechanisms, we exposed NCI-H358, NCI-H1373, and MIAPaCa2 cell lines harboring KRAS-G12C mutations to increasing concentrations of sotorasib or adagrasib over 6 months. The resulting resistant cells proliferate normally in the presence of 10 μM sotorasib or adagrasib. Sotorasib-resistant cells designated as NCI-H358S-R, NCI-H1373S-R, and MIAPaCa2S-R remarkably remain sensitive to adagrasib, suggesting but not proving that the resistant cells remain dependent on mutant KRAS for survival. Adagrasib-resistant cells designated as NCI-H358A-R, NCI-H1373A-R, and MIAPaCa2A-R in contrast remain resistant to both sotorasib and adagrasib. Treatment of adagrasib-resistant cells with 500 nM adagrasib attenuated KRAS activity, however, this was compensated by activation of varied receptor tyrosine kinases (RTKs) to restore phospho-ERK levels, a surrogate marker of RAS activity. Moreover, treatment of de novo resistant NSCLC cells lines NCI-H2030, NCI-H1792, and NCI-H23 or NSCLC patient derived organoids (PDOs) with 500 nM adagrasib resulted in sustained phospho-ERK levels through activation of RTKs. These results indicate the need to simultaneously reduce both KRAS G12C and compensating RTK activity to effectively treat NSCLC. The majority of oncogenic RTKs are dependent on the molecular chaperone HSP90 to maintain stability. Therefore, a heterobifunctional chaperone mediated protein (CHAMP) degrader, RNK07421, was designed to specifically target both KRAS G12C and HSP90. RNK07421 induces an artificial ternary complex between KRAS G12C and HSP90, while also inhibiting the activity of both proteins. The RNK07421 coordinated KRAS G12C-HSP90 interaction promotes the proteasome degradation of KRAS G12C likely via HSP90 associated E3-ligases. Treatment of adagrasib resistant NSCLC cells and PDOs with RNK07421 resulted in reduced levels of KRAS G12C and phospho-ERK along with resistance enabling RTKs: EGFR, BRAF and FGFR2. Furthermore, in vivo treatment of resistant NSCLC cells with RNK07421 demonstrated dramatic tumor reduction as compared to G12Ci. Together these observations indicate that the novel mechanisms of action of RNK07421 may provide several advantages to G12Cis and possibly other targeted protein degradation agents to effectively treat KRAS G12C dependent NSCLC. Citation Format: Ines Pulido, Jennifer M. Graeber, Brianna C. Borger, Kevin P. Foley, Weiwen Ying, Chenghao Ying, Jinhua Li, Yaya Wang, Yuetong Sun, Yan Dai, Guoqiang Wang, Thomas L. Prince, Takeshi Shimamura. Overcoming KRAS G12C inhibitor resistance with chaperone-mediated protein degrader in NSCLC [abstract]. In: Proceedings of the AACR Special Conference: Targeting RAS; 2023 Mar 5-8; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Res 2023;21(5_Suppl):Abstract nr B026.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava的应助被sun采纳,获得10
12秒前
19秒前
动听一德完成签到,获得积分10
19秒前
领导范儿的应助被ClaraClark591采纳,获得30
22秒前
30秒前
32秒前
sun发布了新的文献求助10
35秒前
ClaraClark591发布了新的文献求助30
37秒前
威武的又琴完成签到,获得积分10
41秒前
闪闪小凡完成签到,获得积分10
46秒前
54秒前
369ninja发布了新的文献求助10
59秒前
Tashanzhishi完成签到,获得积分10
1分钟前
优美的烙完成签到,获得积分10
1分钟前
打打的应助被科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
科目三的应助被科研通管家采纳,获得10
1分钟前
奔跑的应助被科研通管家采纳,获得10
1分钟前
愉快的惋庭完成签到,获得积分10
1分钟前
等待剑完成签到,获得积分10
1分钟前
1分钟前
Maestro_S的应助被爱学习的doge采纳,获得10
1分钟前
1分钟前
2分钟前
孙老师完成签到 ,获得积分10
2分钟前
AiQi完成签到 ,获得积分10
2分钟前
sfwrbh完成签到,获得积分10
2分钟前
多情的中蓝完成签到,获得积分10
2分钟前
甜蜜语堂完成签到,获得积分10
2分钟前
李爱国的应助被科研通管家采纳,获得10
3分钟前
Maestro_S的应助被科研通管家采纳,获得10
3分钟前
大医仁心完成签到 ,获得积分0
3分钟前
Ali发布了新的文献求助10
3分钟前
淡然的易槐完成签到,获得积分10
3分钟前
清脆妙梦发布了新的文献求助40
3分钟前
丰富的藏鸟完成签到,获得积分10
3分钟前
4分钟前
漂亮秋荷完成签到,获得积分10
4分钟前
Xuezhuoxin完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179956
求助须知:如何正确求助?哪些是违规求助? 9570170
关于积分的说明 21808444
捐赠科研通 7775818
什么是DOI,文献DOI怎么找? 3433251
关于科研通互助平台的介绍 2557352
邀请新用户注册赠送积分活动 2478958